abstract |
The present invention relates to a medicament for treating cancer, neurodegenerative diseases, conditions associated with accumulated amyloid β peptide deposits, tau protein levels, and / or accumulation of α-synuclein by administering a HAT modulator and an HDAC modulator to a subject. Compositions and methods are provided. |